Orejón de Luna G, Ochoa Sangrador C. A quadrivalent vaccine against human papillomavirus, prevent high-grade malignancy cervical lesions associated to 16 an 18 serotypes, in young women without previous infection. Rev Pediatr Aten Primaria. 2008;10 Supl 1;S111-5.